Auris Medical Holding Ag Stock Predictions

Healthcare > Biotechnology

Buy EARS

*Your capital is at risk

$0.750

-0.0010 (-0.133%)

At Close: May 27, 2022

Currently predicting for Mon, 8 Jun 2026

EARS Prediction Chart

EARS Predictions History

Latest community submissions for EARS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Mike.Thorne.88713	Sep 19, 2018	$0.290 +0.69%	$0.290	X	99.30%	3
JS Pro	Dec 29, 2017	$0.570 -3.47%	$0.590	V	96.50%	0
Haribabu.LT.16551	Dec 29, 2017	$0.750 +27.01%	$0.590	X	73.00%	0
David.England.16533	Dec 29, 2017	$0.326 -44.79%	$0.590	V	55.20%	0
JS Pro	Sep 25, 2017	$0.799 +3.75%	$0.770	V	96.20%	0
Joseph Rather	Jun 28, 2017	$0.81 +10.41%	$0.730	X	89.60%	0
JS Pro	Apr 13, 2017	$0.710 -5.33%	$0.750	X	94.70%	0
Dr§hocker	Apr 13, 2017	$0.700 -6.67%	$0.750	X	93.30%	0
Drew.Robertson.4311	Mar 15, 2017	$1.10 +30.18%	$0.84	X	69.80%	0
Elawad	Feb 6, 2017	$1.51 +18.90%	$1.27	X	81.10%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for EARS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT AURIS MEDICAL HOLDING AG

Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by